Thomas Burris, chair of pharmacological and physiological science at Saint Louis University, and his colleagues examined compounds that target a protein called REV-ERB.
"It has been suggested that REV-ERB is a core component of our clock," said Burris.
"Mice without it are arrhythmic. This study demonstrated that when we give mice a synthetic compound that turns REV-ERB on, it altered their circadian rhythm," Burris said.
Circadian rhythm refers to biological processes that cycle every 24 hours. In mammals, the internal clock that maintains circadian rhythm is essential for normal physiological functions.
The team examined effects of the REV-ERB drug on patterns of sleep and wakefulness and found that the compound increases wakefulness, reduces REM and slow-wave sleep, and, notably, decreases anxiety.
This is an interesting finding because it is unusual, researchers said. Frequently, drugs that increase arousal (wakefulness) also increase anxiety and drugs that decrease anxiety also decrease arousal. An exception to this common pattern is nicotine.
The REV-ERB drug, on the other hand, appears to target the clock in a way that is distinct from these common pathways.
Drug addiction has a circadian component and mice with mutations in "clock genes" (genes that affect our internal clocks) have altered responsiveness to the reward associated with cocaine, morphine and alcohol.
Burris speculated that REV-ERB targeted drug effect on the clock would modulate reward-seeking behaviour, and so may be useful in treating addiction.
The research is published in the journal Nature Communications.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
